Prospera Financial Services Inc Sells 19,965 Shares of Colgate-Palmolive Company $CL

Prospera Financial Services Inc trimmed its holdings in Colgate-Palmolive Company (NYSE:CL) by 47.8% in the third quarter, Holdings Channel reports. The institutional investor owned 21,793 shares of the company’s stock after selling 19,965 shares during the period. Prospera Financial Services Inc’s holdings in Colgate-Palmolive were worth $1,743,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of the company. ProShare Advisors LLC lifted its holdings in Colgate-Palmolive by 11.0% in the third quarter. ProShare Advisors LLC now owns 2,047,542 shares of the company’s stock valued at $163,681,000 after buying an additional 202,379 shares during the period. Asset Management One Co. Ltd. lifted its stake in shares of Colgate-Palmolive by 3.9% in the 3rd quarter. Asset Management One Co. Ltd. now owns 422,292 shares of the company’s stock valued at $33,758,000 after purchasing an additional 16,017 shares during the period. Cidel Asset Management Inc. boosted its position in shares of Colgate-Palmolive by 13.6% during the 2nd quarter. Cidel Asset Management Inc. now owns 329,060 shares of the company’s stock valued at $29,912,000 after purchasing an additional 39,413 shares in the last quarter. Vanguard Group Inc. grew its stake in Colgate-Palmolive by 1.2% during the second quarter. Vanguard Group Inc. now owns 82,751,689 shares of the company’s stock worth $7,522,129,000 after purchasing an additional 993,432 shares during the period. Finally, TD Waterhouse Canada Inc. increased its holdings in Colgate-Palmolive by 248.5% in the third quarter. TD Waterhouse Canada Inc. now owns 87,410 shares of the company’s stock worth $6,909,000 after purchasing an additional 62,327 shares in the last quarter. Institutional investors own 80.41% of the company’s stock.

Insiders Place Their Bets

In other news, COO Panagiotis Tsourapas sold 15,000 shares of Colgate-Palmolive stock in a transaction on Thursday, February 12th. The stock was sold at an average price of $97.81, for a total transaction of $1,467,150.00. Following the sale, the chief operating officer directly owned 10,415 shares in the company, valued at $1,018,691.15. The trade was a 59.02% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO Stanley J. Sutula III sold 97,843 shares of the business’s stock in a transaction dated Wednesday, February 4th. The stock was sold at an average price of $94.27, for a total transaction of $9,223,659.61. Following the completion of the transaction, the chief financial officer directly owned 55,310 shares in the company, valued at $5,214,073.70. This trade represents a 63.89% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last quarter, insiders sold 184,683 shares of company stock valued at $17,486,693. 0.34% of the stock is owned by company insiders.

Colgate-Palmolive Trading Up 0.5%

NYSE:CL opened at $96.61 on Friday. Colgate-Palmolive Company has a 52 week low of $74.54 and a 52 week high of $100.18. The firm has a 50-day moving average price of $83.80 and a two-hundred day moving average price of $81.90. The company has a debt-to-equity ratio of 5.90, a quick ratio of 0.27 and a current ratio of 0.42. The firm has a market cap of $77.87 billion, a price-to-earnings ratio of 36.87, a price-to-earnings-growth ratio of 4.34 and a beta of 0.29.

Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, January 30th. The company reported $0.95 earnings per share for the quarter, topping analysts’ consensus estimates of $0.91 by $0.04. The firm had revenue of $5.23 billion for the quarter, compared to the consensus estimate of $5.13 billion. Colgate-Palmolive had a return on equity of 353.72% and a net margin of 10.45%.The company’s revenue was up 5.8% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.91 EPS. On average, equities analysts expect that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, February 13th. Shareholders of record on Wednesday, January 21st were paid a $0.52 dividend. This represents a $2.08 dividend on an annualized basis and a yield of 2.2%. The ex-dividend date was Wednesday, January 21st. Colgate-Palmolive’s dividend payout ratio is 79.39%.

Wall Street Analyst Weigh In

CL has been the topic of a number of research analyst reports. Wells Fargo & Company increased their price target on Colgate-Palmolive from $86.00 to $94.00 and gave the stock an “equal weight” rating in a report on Sunday, February 1st. Raymond James Financial dropped their price target on Colgate-Palmolive from $105.00 to $95.00 and set an “outperform” rating on the stock in a research note on Monday, October 20th. Morgan Stanley boosted their price objective on Colgate-Palmolive from $87.00 to $100.00 and gave the company an “overweight” rating in a report on Monday, February 2nd. The Goldman Sachs Group reissued a “buy” rating and issued a $94.00 price target on shares of Colgate-Palmolive in a research report on Saturday, January 31st. Finally, JPMorgan Chase & Co. raised their price objective on shares of Colgate-Palmolive from $93.00 to $97.00 and gave the company an “overweight” rating in a research note on Monday, February 2nd. Eleven investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $94.38.

About Colgate-Palmolive

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.